Balyasny Asset Management’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-136,687
Closed -$139K 2366
2024
Q4
$139K Buy
+136,687
New +$139K ﹤0.01% 1784
2024
Q3
Sell
-31,773
Closed -$11.4K 2323
2024
Q2
$11.4K Buy
+31,773
New +$11.4K ﹤0.01% 1853
2023
Q1
Sell
-21,355
Closed -$67.1K 2595
2022
Q4
$67.1K Buy
+21,355
New +$67.1K ﹤0.01% 1869
2022
Q3
Sell
-25,900
Closed -$107K 2715
2022
Q2
$107K Buy
25,900
+7,753
+43% +$32K ﹤0.01% 1826
2022
Q1
$105K Buy
+18,147
New +$105K ﹤0.01% 1779
2020
Q2
Sell
-92,994
Closed -$592K 1285
2020
Q1
$592K Buy
92,994
+51,863
+126% +$330K 0.01% 745
2019
Q4
$344K Buy
+41,131
New +$344K ﹤0.01% 933
2019
Q3
Sell
-17,264
Closed -$186K 1371
2019
Q2
$186K Buy
+17,264
New +$186K ﹤0.01% 1266
2019
Q1
Sell
-25,806
Closed -$296K 1497
2018
Q4
$296K Buy
+25,806
New +$296K ﹤0.01% 1133
2017
Q4
Sell
-14,451
Closed -$217K 1970
2017
Q3
$217K Sell
14,451
-337,249
-96% -$5.06M ﹤0.01% 1466
2017
Q2
$3.1M Buy
+351,700
New +$3.1M 0.01% 696
2016
Q2
Sell
-163,697
Closed -$990K 1207
2016
Q1
$990K Sell
163,697
-1,441,193
-90% -$8.72M 0.01% 581
2015
Q4
$14.7M Buy
1,604,890
+1,527,638
+1,977% +$13.9M 0.1% 249
2015
Q3
$436K Buy
+77,252
New +$436K ﹤0.01% 668
2015
Q1
Sell
-740,857
Closed -$11.3M 821
2014
Q4
$11.3M Buy
740,857
+560,857
+312% +$8.53M 0.1% 223
2014
Q3
$1.94M Buy
+180,000
New +$1.94M 0.02% 393
2014
Q2
Sell
-276,600
Closed -$5M 559
2014
Q1
$5M Buy
276,600
+77,135
+39% +$1.39M 0.06% 291
2013
Q4
$2.77M Buy
+199,465
New +$2.77M 0.04% 310